Role of radiation in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory non-Hodgkin lymphoma: Current studies and future prospects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of radiation in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory non-Hodgkin lymphoma: Current studies and future prospects

Published:2024-07 Issue: Volume:199 Page:104390
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Yu Lingzi^ORCID,Zou Rui,He Jiajie,Qu Changju

Funder

Soochow University

Publisher

Elsevier BV

Reference74 articles.

1. Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR Tcell therapy;Ababneh;Haematologica,2023

2. Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL;Abramson;J. Clin. Oncol.,2018

3. Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: a multicenter observational study;Alarcon Tomas;Blood,2021

4. Tandem induction radiation and chimeric antigen receptor T cell therapy in patients with relapsed or refractory non-Hodgkin lymphoma;Arscott;Int. J. Radiat. Oncol., Biol., Phys.,2018

5. Clinical impact of immune cells and their spatial interactions in diffuse large B-cell lymphoma microenvironment;Autio;Clin. Cancer Res.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP